# Barox Co., Ltd. – FDA Inspection, May 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/barox-co-ltd/5ae03b38-dbe9-4a98-a76e-1cd247a49a26
Source feed: FDA_Inspections

> FDA inspection 1052335 of Barox Co., Ltd., May 18, 2018. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052335
- Company Name: Barox Co., Ltd.
- Inspection Date: 2018-05-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sangeeta-m-khurana/bed4533f-a9aa-47c5-9e0b-f20ad36461aa)

Company: https://www.keypedia.com/companies/barox-co-ltd/18571fc5-78e8-4569-a15d-ac91b22c29ca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c